COVID-19 Impact on Global Diabetes Care Drugs Market Size, Status and Forecast 2020-2026
Diabetes is a group of metabolic diseases characterized by hyperglycemia. HYPERGLYCEMIA is caused by defective insulin secretion or impaired biological function, or both. The long-term existence of high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels and nerves.Diabetes care drugs are used to treat diabetes.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Diabetes Care Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Diabetes Care Drugs industry.
Based on our recent survey, we have several different scenarios about the Diabetes Care Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 63620 million in 2019. The market size of Diabetes Care Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Care Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Care Drugs market in terms of revenue.
Players, stakeholders, and other participants in the global Diabetes Care Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Diabetes Care Drugs market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Diabetes Care Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Care Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Care Drugs market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Diabetes Care Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Diabetes Care Drugs industry.
Based on our recent survey, we have several different scenarios about the Diabetes Care Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 63620 million in 2019. The market size of Diabetes Care Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Care Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Care Drugs market in terms of revenue.
Players, stakeholders, and other participants in the global Diabetes Care Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Diabetes Care Drugs market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Diabetes Care Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Care Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Care Drugs market.
The following players are covered in this report:
- Novo Nordisk
- Sanofi
- Eli Lilly
- Biocon
- AstraZeneca
- Bristol Myers Squibb
- Boehringer Ingelheim
- Mylan
- Pfizer
- Johnson & Johnson
- Merck
- Novartis
- Astellas
- Teva
- Oral Anti-diabetic Drugs
- Insulins
- Non-insulin Injectable Drugs
- Other
- Hospital
- Medical Research Institute
- Clinic
- Other
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetes Care Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Diabetes Care Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral Anti-diabetic Drugs
1.4.3 Insulins
1.4.4 Non-insulin Injectable Drugs
1.4.5 Other
1.5 Market by Application
1.5.1 Global Diabetes Care Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Medical Research Institute
1.5.4 Clinic
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Diabetes Care Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Diabetes Care Drugs Industry
1.6.1.1 Diabetes Care Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Diabetes Care Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Diabetes Care Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Diabetes Care Drugs Market Perspective (2015-2026)
2.2 Diabetes Care Drugs Growth Trends by Regions
2.2.1 Diabetes Care Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetes Care Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Diabetes Care Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetes Care Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetes Care Drugs Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Diabetes Care Drugs Players by Market Size
3.1.1 Global Top Diabetes Care Drugs Players by Revenue (2015-2020)
3.1.2 Global Diabetes Care Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetes Care Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetes Care Drugs Market Concentration Ratio
3.2.1 Global Diabetes Care Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetes Care Drugs Revenue in 2019
3.3 Diabetes Care Drugs Key Players Head office and Area Served
3.4 Key Players Diabetes Care Drugs Product Solution and Service
3.5 Date of Enter into Diabetes Care Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Diabetes Care Drugs Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Care Drugs Forecasted Market Size by Type (2021-2026)
5 DIABETES CARE DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Diabetes Care Drugs Market Size by Application (2015-2020)
5.2 Global Diabetes Care Drugs Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Diabetes Care Drugs Market Size (2015-2020)
6.2 Diabetes Care Drugs Key Players in North America (2019-2020)
6.3 North America Diabetes Care Drugs Market Size by Type (2015-2020)
6.4 North America Diabetes Care Drugs Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Diabetes Care Drugs Market Size (2015-2020)
7.2 Diabetes Care Drugs Key Players in Europe (2019-2020)
7.3 Europe Diabetes Care Drugs Market Size by Type (2015-2020)
7.4 Europe Diabetes Care Drugs Market Size by Application (2015-2020)
8 CHINA
8.1 China Diabetes Care Drugs Market Size (2015-2020)
8.2 Diabetes Care Drugs Key Players in China (2019-2020)
8.3 China Diabetes Care Drugs Market Size by Type (2015-2020)
8.4 China Diabetes Care Drugs Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Diabetes Care Drugs Market Size (2015-2020)
9.2 Diabetes Care Drugs Key Players in Japan (2019-2020)
9.3 Japan Diabetes Care Drugs Market Size by Type (2015-2020)
9.4 Japan Diabetes Care Drugs Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Diabetes Care Drugs Market Size (2015-2020)
10.2 Diabetes Care Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetes Care Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetes Care Drugs Market Size by Application (2015-2020)
11 INDIA
11.1 India Diabetes Care Drugs Market Size (2015-2020)
11.2 Diabetes Care Drugs Key Players in India (2019-2020)
11.3 India Diabetes Care Drugs Market Size by Type (2015-2020)
11.4 India Diabetes Care Drugs Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Diabetes Care Drugs Market Size (2015-2020)
12.2 Diabetes Care Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetes Care Drugs Market Size by Type (2015-2020)
12.4 Central & South America Diabetes Care Drugs Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Details
13.1.2 Novo Nordisk Business Overview and Its Total Revenue
13.1.3 Novo Nordisk Diabetes Care Drugs Introduction
13.1.4 Novo Nordisk Revenue in Diabetes Care Drugs Business (2015-2020))
13.1.5 Novo Nordisk Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview and Its Total Revenue
13.2.3 Sanofi Diabetes Care Drugs Introduction
13.2.4 Sanofi Revenue in Diabetes Care Drugs Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview and Its Total Revenue
13.3.3 Eli Lilly Diabetes Care Drugs Introduction
13.3.4 Eli Lilly Revenue in Diabetes Care Drugs Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Biocon
13.4.1 Biocon Company Details
13.4.2 Biocon Business Overview and Its Total Revenue
13.4.3 Biocon Diabetes Care Drugs Introduction
13.4.4 Biocon Revenue in Diabetes Care Drugs Business (2015-2020)
13.4.5 Biocon Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview and Its Total Revenue
13.5.3 AstraZeneca Diabetes Care Drugs Introduction
13.5.4 AstraZeneca Revenue in Diabetes Care Drugs Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Bristol Myers Squibb
13.6.1 Bristol Myers Squibb Company Details
13.6.2 Bristol Myers Squibb Business Overview and Its Total Revenue
13.6.3 Bristol Myers Squibb Diabetes Care Drugs Introduction
13.6.4 Bristol Myers Squibb Revenue in Diabetes Care Drugs Business (2015-2020)
13.6.5 Bristol Myers Squibb Recent Development
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Company Details
13.7.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.7.3 Boehringer Ingelheim Diabetes Care Drugs Introduction
13.7.4 Boehringer Ingelheim Revenue in Diabetes Care Drugs Business (2015-2020)
13.7.5 Boehringer Ingelheim Recent Development
13.8 Mylan
13.8.1 Mylan Company Details
13.8.2 Mylan Business Overview and Its Total Revenue
13.8.3 Mylan Diabetes Care Drugs Introduction
13.8.4 Mylan Revenue in Diabetes Care Drugs Business (2015-2020)
13.8.5 Mylan Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview and Its Total Revenue
13.9.3 Pfizer Diabetes Care Drugs Introduction
13.9.4 Pfizer Revenue in Diabetes Care Drugs Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview and Its Total Revenue
13.10.3 Johnson & Johnson Diabetes Care Drugs Introduction
13.10.4 Johnson & Johnson Revenue in Diabetes Care Drugs Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development
13.11 Merck
10.11.1 Merck Company Details
10.11.2 Merck Business Overview and Its Total Revenue
10.11.3 Merck Diabetes Care Drugs Introduction
10.11.4 Merck Revenue in Diabetes Care Drugs Business (2015-2020)
10.11.5 Merck Recent Development
13.12 Novartis
10.12.1 Novartis Company Details
10.12.2 Novartis Business Overview and Its Total Revenue
10.12.3 Novartis Diabetes Care Drugs Introduction
10.12.4 Novartis Revenue in Diabetes Care Drugs Business (2015-2020)
10.12.5 Novartis Recent Development
13.13 Astellas
10.13.1 Astellas Company Details
10.13.2 Astellas Business Overview and Its Total Revenue
10.13.3 Astellas Diabetes Care Drugs Introduction
10.13.4 Astellas Revenue in Diabetes Care Drugs Business (2015-2020)
10.13.5 Astellas Recent Development
13.14 Teva
10.14.1 Teva Company Details
10.14.2 Teva Business Overview and Its Total Revenue
10.14.3 Teva Diabetes Care Drugs Introduction
10.14.4 Teva Revenue in Diabetes Care Drugs Business (2015-2020)
10.14.5 Teva Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetes Care Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Diabetes Care Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral Anti-diabetic Drugs
1.4.3 Insulins
1.4.4 Non-insulin Injectable Drugs
1.4.5 Other
1.5 Market by Application
1.5.1 Global Diabetes Care Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Medical Research Institute
1.5.4 Clinic
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Diabetes Care Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Diabetes Care Drugs Industry
1.6.1.1 Diabetes Care Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Diabetes Care Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Diabetes Care Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Diabetes Care Drugs Market Perspective (2015-2026)
2.2 Diabetes Care Drugs Growth Trends by Regions
2.2.1 Diabetes Care Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetes Care Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Diabetes Care Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetes Care Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetes Care Drugs Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Diabetes Care Drugs Players by Market Size
3.1.1 Global Top Diabetes Care Drugs Players by Revenue (2015-2020)
3.1.2 Global Diabetes Care Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetes Care Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetes Care Drugs Market Concentration Ratio
3.2.1 Global Diabetes Care Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetes Care Drugs Revenue in 2019
3.3 Diabetes Care Drugs Key Players Head office and Area Served
3.4 Key Players Diabetes Care Drugs Product Solution and Service
3.5 Date of Enter into Diabetes Care Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Diabetes Care Drugs Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Care Drugs Forecasted Market Size by Type (2021-2026)
5 DIABETES CARE DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Diabetes Care Drugs Market Size by Application (2015-2020)
5.2 Global Diabetes Care Drugs Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Diabetes Care Drugs Market Size (2015-2020)
6.2 Diabetes Care Drugs Key Players in North America (2019-2020)
6.3 North America Diabetes Care Drugs Market Size by Type (2015-2020)
6.4 North America Diabetes Care Drugs Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Diabetes Care Drugs Market Size (2015-2020)
7.2 Diabetes Care Drugs Key Players in Europe (2019-2020)
7.3 Europe Diabetes Care Drugs Market Size by Type (2015-2020)
7.4 Europe Diabetes Care Drugs Market Size by Application (2015-2020)
8 CHINA
8.1 China Diabetes Care Drugs Market Size (2015-2020)
8.2 Diabetes Care Drugs Key Players in China (2019-2020)
8.3 China Diabetes Care Drugs Market Size by Type (2015-2020)
8.4 China Diabetes Care Drugs Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Diabetes Care Drugs Market Size (2015-2020)
9.2 Diabetes Care Drugs Key Players in Japan (2019-2020)
9.3 Japan Diabetes Care Drugs Market Size by Type (2015-2020)
9.4 Japan Diabetes Care Drugs Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Diabetes Care Drugs Market Size (2015-2020)
10.2 Diabetes Care Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetes Care Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetes Care Drugs Market Size by Application (2015-2020)
11 INDIA
11.1 India Diabetes Care Drugs Market Size (2015-2020)
11.2 Diabetes Care Drugs Key Players in India (2019-2020)
11.3 India Diabetes Care Drugs Market Size by Type (2015-2020)
11.4 India Diabetes Care Drugs Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Diabetes Care Drugs Market Size (2015-2020)
12.2 Diabetes Care Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetes Care Drugs Market Size by Type (2015-2020)
12.4 Central & South America Diabetes Care Drugs Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Details
13.1.2 Novo Nordisk Business Overview and Its Total Revenue
13.1.3 Novo Nordisk Diabetes Care Drugs Introduction
13.1.4 Novo Nordisk Revenue in Diabetes Care Drugs Business (2015-2020))
13.1.5 Novo Nordisk Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview and Its Total Revenue
13.2.3 Sanofi Diabetes Care Drugs Introduction
13.2.4 Sanofi Revenue in Diabetes Care Drugs Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview and Its Total Revenue
13.3.3 Eli Lilly Diabetes Care Drugs Introduction
13.3.4 Eli Lilly Revenue in Diabetes Care Drugs Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Biocon
13.4.1 Biocon Company Details
13.4.2 Biocon Business Overview and Its Total Revenue
13.4.3 Biocon Diabetes Care Drugs Introduction
13.4.4 Biocon Revenue in Diabetes Care Drugs Business (2015-2020)
13.4.5 Biocon Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview and Its Total Revenue
13.5.3 AstraZeneca Diabetes Care Drugs Introduction
13.5.4 AstraZeneca Revenue in Diabetes Care Drugs Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Bristol Myers Squibb
13.6.1 Bristol Myers Squibb Company Details
13.6.2 Bristol Myers Squibb Business Overview and Its Total Revenue
13.6.3 Bristol Myers Squibb Diabetes Care Drugs Introduction
13.6.4 Bristol Myers Squibb Revenue in Diabetes Care Drugs Business (2015-2020)
13.6.5 Bristol Myers Squibb Recent Development
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Company Details
13.7.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.7.3 Boehringer Ingelheim Diabetes Care Drugs Introduction
13.7.4 Boehringer Ingelheim Revenue in Diabetes Care Drugs Business (2015-2020)
13.7.5 Boehringer Ingelheim Recent Development
13.8 Mylan
13.8.1 Mylan Company Details
13.8.2 Mylan Business Overview and Its Total Revenue
13.8.3 Mylan Diabetes Care Drugs Introduction
13.8.4 Mylan Revenue in Diabetes Care Drugs Business (2015-2020)
13.8.5 Mylan Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview and Its Total Revenue
13.9.3 Pfizer Diabetes Care Drugs Introduction
13.9.4 Pfizer Revenue in Diabetes Care Drugs Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview and Its Total Revenue
13.10.3 Johnson & Johnson Diabetes Care Drugs Introduction
13.10.4 Johnson & Johnson Revenue in Diabetes Care Drugs Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development
13.11 Merck
10.11.1 Merck Company Details
10.11.2 Merck Business Overview and Its Total Revenue
10.11.3 Merck Diabetes Care Drugs Introduction
10.11.4 Merck Revenue in Diabetes Care Drugs Business (2015-2020)
10.11.5 Merck Recent Development
13.12 Novartis
10.12.1 Novartis Company Details
10.12.2 Novartis Business Overview and Its Total Revenue
10.12.3 Novartis Diabetes Care Drugs Introduction
10.12.4 Novartis Revenue in Diabetes Care Drugs Business (2015-2020)
10.12.5 Novartis Recent Development
13.13 Astellas
10.13.1 Astellas Company Details
10.13.2 Astellas Business Overview and Its Total Revenue
10.13.3 Astellas Diabetes Care Drugs Introduction
10.13.4 Astellas Revenue in Diabetes Care Drugs Business (2015-2020)
10.13.5 Astellas Recent Development
13.14 Teva
10.14.1 Teva Company Details
10.14.2 Teva Business Overview and Its Total Revenue
10.14.3 Teva Diabetes Care Drugs Introduction
10.14.4 Teva Revenue in Diabetes Care Drugs Business (2015-2020)
10.14.5 Teva Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Diabetes Care Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetes Care Drugs Revenue
Table 3. Ranking of Global Top Diabetes Care Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetes Care Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Anti-diabetic Drugs
Table 6. Key Players of Insulins
Table 7. Key Players of Non-insulin Injectable Drugs
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Diabetes Care Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Diabetes Care Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Diabetes Care Drugs Players to Combat Covid-19 Impact
Table 14. Global Diabetes Care Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Diabetes Care Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Diabetes Care Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Diabetes Care Drugs Market Share by Regions (2015-2020)
Table 18. Global Diabetes Care Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Diabetes Care Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Diabetes Care Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Diabetes Care Drugs Players
Table 25. Global Diabetes Care Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Diabetes Care Drugs Market Share by Players (2015-2020)
Table 27. Global Top Diabetes Care Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Care Drugs as of 2019)
Table 28. Global Diabetes Care Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Diabetes Care Drugs Product Solution and Service
Table 31. Date of Enter into Diabetes Care Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Diabetes Care Drugs Market Size Share by Type (2015-2020)
Table 35. Global Diabetes Care Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Diabetes Care Drugs Market Size Share by Application (2015-2020)
Table 37. Global Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Diabetes Care Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 41. North America Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Diabetes Care Drugs Market Share by Type (2015-2020)
Table 43. North America Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Diabetes Care Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 47. Europe Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Diabetes Care Drugs Market Share by Type (2015-2020)
Table 49. Europe Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Diabetes Care Drugs Market Share by Application (2015-2020)
Table 51. China Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 52. China Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 53. China Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. China Diabetes Care Drugs Market Share by Type (2015-2020)
Table 55. China Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. China Diabetes Care Drugs Market Share by Application (2015-2020)
Table 57. Japan Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 59. Japan Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Diabetes Care Drugs Market Share by Type (2015-2020)
Table 61. Japan Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Diabetes Care Drugs Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 65. Southeast Asia Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Diabetes Care Drugs Market Share by Type (2015-2020)
Table 67. Southeast Asia Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Diabetes Care Drugs Market Share by Application (2015-2020)
Table 69. India Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 70. India Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 71. India Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. India Diabetes Care Drugs Market Share by Type (2015-2020)
Table 73. India Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. India Diabetes Care Drugs Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 77. Central & South America Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Diabetes Care Drugs Market Share by Type (2015-2020)
Table 79. Central & South America Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Diabetes Care Drugs Market Share by Application (2015-2020)
Table 81. Novo Nordisk Company Details
Table 82. Novo Nordisk Business Overview
Table 83. Novo Nordisk Product
Table 84. Novo Nordisk Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 85. Novo Nordisk Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Product
Table 89. Sanofi Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 90. Sanofi Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Product
Table 94. Eli Lilly Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 95. Eli Lilly Recent Development
Table 96. Biocon Company Details
Table 97. Biocon Business Overview
Table 98. Biocon Product
Table 99. Biocon Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 100. Biocon Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Product
Table 104. AstraZeneca Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 105. AstraZeneca Recent Development
Table 106. Bristol Myers Squibb Company Details
Table 107. Bristol Myers Squibb Business Overview
Table 108. Bristol Myers Squibb Product
Table 109. Bristol Myers Squibb Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 110. Bristol Myers Squibb Recent Development
Table 111. Boehringer Ingelheim Company Details
Table 112. Boehringer Ingelheim Business Overview
Table 113. Boehringer Ingelheim Product
Table 114. Boehringer Ingelheim Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 115. Boehringer Ingelheim Recent Development
Table 116. Mylan Business Overview
Table 117. Mylan Product
Table 118. Mylan Company Details
Table 119. Mylan Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 120. Mylan Recent Development
Table 121. Pfizer Company Details
Table 122. Pfizer Business Overview
Table 123. Pfizer Product
Table 124. Pfizer Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 125. Pfizer Recent Development
Table 126. Johnson & Johnson Company Details
Table 127. Johnson & Johnson Business Overview
Table 128. Johnson & Johnson Product
Table 129. Johnson & Johnson Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 130. Johnson & Johnson Recent Development
Table 131. Merck Company Details
Table 132. Merck Business Overview
Table 133. Merck Product
Table 134. Merck Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 135. Merck Recent Development
Table 136. Novartis Company Details
Table 137. Novartis Business Overview
Table 138. Novartis Product
Table 139. Novartis Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 140. Novartis Recent Development
Table 141. Astellas Company Details
Table 142. Astellas Business Overview
Table 143. Astellas Product
Table 144. Astellas Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 145. Astellas Recent Development
Table 146. Teva Company Details
Table 147. Teva Business Overview
Table 148. Teva Product
Table 149. Teva Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 150. Teva Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 1. Diabetes Care Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetes Care Drugs Revenue
Table 3. Ranking of Global Top Diabetes Care Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetes Care Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Anti-diabetic Drugs
Table 6. Key Players of Insulins
Table 7. Key Players of Non-insulin Injectable Drugs
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Diabetes Care Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Diabetes Care Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Diabetes Care Drugs Players to Combat Covid-19 Impact
Table 14. Global Diabetes Care Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Diabetes Care Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Diabetes Care Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Diabetes Care Drugs Market Share by Regions (2015-2020)
Table 18. Global Diabetes Care Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Diabetes Care Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Diabetes Care Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Diabetes Care Drugs Players
Table 25. Global Diabetes Care Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Diabetes Care Drugs Market Share by Players (2015-2020)
Table 27. Global Top Diabetes Care Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Care Drugs as of 2019)
Table 28. Global Diabetes Care Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Diabetes Care Drugs Product Solution and Service
Table 31. Date of Enter into Diabetes Care Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Diabetes Care Drugs Market Size Share by Type (2015-2020)
Table 35. Global Diabetes Care Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Diabetes Care Drugs Market Size Share by Application (2015-2020)
Table 37. Global Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Diabetes Care Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 41. North America Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Diabetes Care Drugs Market Share by Type (2015-2020)
Table 43. North America Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Diabetes Care Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 47. Europe Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Diabetes Care Drugs Market Share by Type (2015-2020)
Table 49. Europe Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Diabetes Care Drugs Market Share by Application (2015-2020)
Table 51. China Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 52. China Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 53. China Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. China Diabetes Care Drugs Market Share by Type (2015-2020)
Table 55. China Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. China Diabetes Care Drugs Market Share by Application (2015-2020)
Table 57. Japan Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 59. Japan Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Diabetes Care Drugs Market Share by Type (2015-2020)
Table 61. Japan Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Diabetes Care Drugs Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 65. Southeast Asia Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Diabetes Care Drugs Market Share by Type (2015-2020)
Table 67. Southeast Asia Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Diabetes Care Drugs Market Share by Application (2015-2020)
Table 69. India Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 70. India Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 71. India Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. India Diabetes Care Drugs Market Share by Type (2015-2020)
Table 73. India Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. India Diabetes Care Drugs Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Diabetes Care Drugs Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Diabetes Care Drugs Market Share (2019-2020)
Table 77. Central & South America Diabetes Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Diabetes Care Drugs Market Share by Type (2015-2020)
Table 79. Central & South America Diabetes Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Diabetes Care Drugs Market Share by Application (2015-2020)
Table 81. Novo Nordisk Company Details
Table 82. Novo Nordisk Business Overview
Table 83. Novo Nordisk Product
Table 84. Novo Nordisk Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 85. Novo Nordisk Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Product
Table 89. Sanofi Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 90. Sanofi Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Product
Table 94. Eli Lilly Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 95. Eli Lilly Recent Development
Table 96. Biocon Company Details
Table 97. Biocon Business Overview
Table 98. Biocon Product
Table 99. Biocon Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 100. Biocon Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Product
Table 104. AstraZeneca Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 105. AstraZeneca Recent Development
Table 106. Bristol Myers Squibb Company Details
Table 107. Bristol Myers Squibb Business Overview
Table 108. Bristol Myers Squibb Product
Table 109. Bristol Myers Squibb Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 110. Bristol Myers Squibb Recent Development
Table 111. Boehringer Ingelheim Company Details
Table 112. Boehringer Ingelheim Business Overview
Table 113. Boehringer Ingelheim Product
Table 114. Boehringer Ingelheim Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 115. Boehringer Ingelheim Recent Development
Table 116. Mylan Business Overview
Table 117. Mylan Product
Table 118. Mylan Company Details
Table 119. Mylan Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 120. Mylan Recent Development
Table 121. Pfizer Company Details
Table 122. Pfizer Business Overview
Table 123. Pfizer Product
Table 124. Pfizer Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 125. Pfizer Recent Development
Table 126. Johnson & Johnson Company Details
Table 127. Johnson & Johnson Business Overview
Table 128. Johnson & Johnson Product
Table 129. Johnson & Johnson Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 130. Johnson & Johnson Recent Development
Table 131. Merck Company Details
Table 132. Merck Business Overview
Table 133. Merck Product
Table 134. Merck Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 135. Merck Recent Development
Table 136. Novartis Company Details
Table 137. Novartis Business Overview
Table 138. Novartis Product
Table 139. Novartis Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 140. Novartis Recent Development
Table 141. Astellas Company Details
Table 142. Astellas Business Overview
Table 143. Astellas Product
Table 144. Astellas Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 145. Astellas Recent Development
Table 146. Teva Company Details
Table 147. Teva Business Overview
Table 148. Teva Product
Table 149. Teva Revenue in Diabetes Care Drugs Business (2015-2020) (Million US$)
Table 150. Teva Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Diabetes Care Drugs Market Share by Type: 2020 VS 2026
Figure 2. Oral Anti-diabetic Drugs Features
Figure 3. Insulins Features
Figure 4. Non-insulin Injectable Drugs Features
Figure 5. Other Features
Figure 6. Global Diabetes Care Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Medical Research Institute Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Diabetes Care Drugs Report Years Considered
Figure 12. Global Diabetes Care Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Diabetes Care Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global Diabetes Care Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Diabetes Care Drugs Market Share by Players in 2019
Figure 17. Global Top Diabetes Care Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Care Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Diabetes Care Drugs Revenue in 2019
Figure 19. North America Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Novo Nordisk Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 30. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Eli Lilly Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 32. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Biocon Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 34. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. AstraZeneca Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 36. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol Myers Squibb Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 38. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Boehringer Ingelheim Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 40. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Mylan Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 42. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 44. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Johnson & Johnson Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 46. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Merck Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 48. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Novartis Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 50. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Astellas Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 52. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Teva Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Figure 1. Global Diabetes Care Drugs Market Share by Type: 2020 VS 2026
Figure 2. Oral Anti-diabetic Drugs Features
Figure 3. Insulins Features
Figure 4. Non-insulin Injectable Drugs Features
Figure 5. Other Features
Figure 6. Global Diabetes Care Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Medical Research Institute Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Diabetes Care Drugs Report Years Considered
Figure 12. Global Diabetes Care Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Diabetes Care Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global Diabetes Care Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Diabetes Care Drugs Market Share by Players in 2019
Figure 17. Global Top Diabetes Care Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Care Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Diabetes Care Drugs Revenue in 2019
Figure 19. North America Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Diabetes Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Novo Nordisk Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 30. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Eli Lilly Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 32. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Biocon Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 34. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. AstraZeneca Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 36. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol Myers Squibb Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 38. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Boehringer Ingelheim Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 40. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Mylan Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 42. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 44. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Johnson & Johnson Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 46. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Merck Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 48. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Novartis Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 50. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Astellas Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 52. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Teva Revenue Growth Rate in Diabetes Care Drugs Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
